	Efficacy and safety of orelabrutinib plus R-CDOP as first-line therapy in diffuse large B-cell lymphoma with high-risk CNS-IPI: a prospective, multicenter, single-arm, phase II study. Front Oncol Guo Y, Wang J, Lei H, Bao C, Chen P, Shou L, Guo Q, Hu B, Xie Y, Zhong S, Qian W, Xiao X. PMID: 42979656 [PubMed]
	Unmasking Panic Disorder in Adults with Leukemia: A Systematic Review of Prevalence, Risk Factors, and Management. Psychopharmacol Bull Sarangal M. PMID: 42979589 [PubMed - indexed for MEDLINE]
	Low tumor burden follicular lymphoma: The state of the art. Hemasphere Hapgood G, Tobin J, Kridel R, Kahl B. PMID: 42979489 [PubMed]
	Chimeric antigen receptor T-cell therapy as a cure for large B-cell lymphoma. Hemasphere Wallace DS, Gupta Y, Casulo C, Osborne W. PMID: 42979173 [PubMed]
	The relationship of homocysteine and its redox forms with renal toxicity after high-dose methotrexate treatment in patients with leukemia or lymphoma. Front Pharmacol Gao SS, Wu CL, Liu ZY, Zheng JX, Zhou HY, Xie JY, Guo JL, Dong WC. PMID: 42978686 [PubMed]
	Prognostic value of cell differentiation-related genes in follicular lymphoma based on integrated single-cell and bulk RNA sequencing. Neoplasma Xiang X, Deng W. PMID: 42978446 [PubMed - as supplied by publisher]
	Pediatric suprasellar primary CNS lymphoma with cavernous sinus invasion and ischemic stroke: a case report and systematic review. Childs Nerv Syst AlShakhs FA, Alruwaili AA, Namer TS, Alsaiari SA, Almomen A, Algarni AA. PMID: 42977864 [PubMed - indexed for MEDLINE]
	Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) and German MDS Study Group. Br J Haematol Stomper J, Kicinski M, Ma T, Meyer T, Chantepie S, Noppeney R, Luppi M, Audisio E, Gri, Neubauer A, Foà R, Van der Velden WJFM, Candoni A, Vrhovac R, Gaidano G, Van Elssen C, Hoogendoorn M, Musso M, Olivieri A, Junghanß C, Bissé E, Antunes S, Baron F, Venditti A, Jansen JH, Wijermans PW, Huls G, Lübbert M. PMID: 42977697 [PubMed - as supplied by publisher]
	Chronic lymphocytic leukemia: recent advances and emerging therapeutic strategies. Blood Res Jung J. PMID: 42975843 [PubMed]
	The "Pearl Sign": A conventional MRI feature for distinguishing brain metastasis from glioblastoma and primary CNS lymphoma. Neuroradiology Yesiloglu EO, Yuzkan S, Senturk YE, Karabiber Deveci C, Danalioglu AN, Puskulluoglu O, Ergin HE, Balsak S, Azar SM, Solaroglu I, Kulac I. PMID: 42975627 [PubMed - as supplied by publisher]
	Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma: Final Analysis of the Phase 2 ROSEWOOD Study. Target Oncol Zinzani PL, , Flowers CR, Bijou F, De Oliveira AC, Song Y, Zhang Q, Brociner M, Bouabdallah K, Ganly P, Zhang H, Yuen S, Johnson R, Trn, Auer R, García-Sancho AM, Pulla MP, Huang S, Shen J, Hirata J, Trotman J. PMID: 42975620 [PubMed - as supplied by publisher]
	Cytogenetic Landscape of Complex Karyotypes Across Hematological Malignancies: Common and Disease-Specific Patterns in a Large Single-Center Cohort. Genes Chromosomes Cancer Alt, Vicdan A, Yürür Kutlay N, Tuncal, Karabulut HG, Ilg. PMID: 42975137 [PubMed - indexed for MEDLINE]
	Feasibility of Shallow Whole-Genome Sequencing-Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma: A Pilot Study. Vet Comp Oncol Kim GH, Jang JH, Kim SH, Ryu MO, Kwon CH, Seo KW. PMID: 42974710 [PubMed - as supplied by publisher]
	Personalized Prediction of Venetoclax-Associated Tumor Lysis Syndrome in Acute Myeloid Leukemia Using Drug Exposure, Genetic Polymorphisms, and Clinical-Laboratory Characteristics. Drug Des Devel Ther Wang C, Lin X, Yang Y, Peng M, Wu F, Zhou J, Xie H, Wang S, Liu M. PMID: 42974127 [PubMed - indexed for MEDLINE]
	Mechanisms and Therapeutic Potential of Resveratrol: Focus on its Effect on Leukemia. Onco Targets Ther Tabei T, Sharifi S, Mezginejad F. PMID: 42974114 [PubMed]
	Malignant remodeling of the bone marrow microenvironment in acute myeloid leukemia: mechanisms and therapeutic implications. Front Oncol Xu W, Han Q, Sun C, Li D. PMID: 42974033 [PubMed]
	Oral versus intravenous melphalan for autologous stem cell transplantation conditioning in lymphoma and multiple myeloma: a retrospective cohort study. Front Oncol Wang J, Guo Y, Zhao J, Wen X, Su L, Hao Z, Yang J. PMID: 42973770 [PubMed]
	Longitudinal changes in bone mineral density, bone turnover markers, and body composition in children and adolescents treated for acute lymphoblastic leukemia. Front Endocrinol (Lausanne) Cattoni A, Molinari S, Capitoli G, Vai S, Carrara S, Galliera E, Massaccesi L, Nicolosi ML, Radaelli S, Sarra M, Tondelli D, Corso R, Speziali G, Biondi A, Balduzzi A, Corbetta S, Sala A. PMID: 42973471 [PubMed - indexed for MEDLINE]
	Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cell Transplantation Program for Patients With Hematologic Malignancy in a Resource-Limited Center in Chile. Ann Transplant Lesina B, Calderón S, Torres V, Salinas J, Teneb E, Reyes D, Carrasco C, Alarcón G, Fuentes M, Soto D, Navia R, Castro I, Zúñiga V, Vásquez N, Orellana C, Del Campo C, Carroza D, Leyton C, Pilleux L. PMID: 42972955 [PubMed - indexed for MEDLINE]
	Challenges in the diagnosis and management of coexisting drop-head syndrome and dysphagia: a case report and review of the literature. J Med Case Rep Malfitano C, Pighetti D, Calvi C, Meneguzzo C, Doretti A, Majnardi AR. PMID: 42972390 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 171186

Page 1 of 8560



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy